We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Preliminary Efficacy Study of WST11 (Stakel®)-Mediated VTP Therapy in Subjects With CNV Associated With AMD

This study has been terminated.
(As two cases of retinal vascular occlusion in patients who received anti-VEGF)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01021956
First Posted: December 1, 2009
Last Update Posted: April 29, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Steba Biotech S.A.
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2014
  Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)